Delivery Order SPE2DB24D2205-SPE2DB24FDWQW
Award Date
7/10/24
Potential Completion Date
7/11/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,048.25 firm fixed-price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 16, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,030.20 firm fixed-price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,258.00 firm fixed-price delivery order is for CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of June 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,961.40 Firm Fixed Price delivery order contract is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has a period of performance through May 14, 2025 and is not set aside for any socioeconomic category. Amerisourcebergen holds a substantial Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,827.72 Firm Fixed Price Delivery Order is for CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,882.35 for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 3, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,878.58 firm-fixed-price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a prescription medication. The contract has a completion date of September 6, 2024. AmerisourceBergen is delivering these pharmaceutical products under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,803.96, is a Firm Fixed Price Delivery Order for CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The contract has an ultimate completion date of June 11, 2025 and is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and this award is associated with the company's $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,385.39, is a delivery order for CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a medical product, with a period of performance through January 17, 2025. The contract is a firm fixed-price arrangement and was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,321.30 Firm Fixed Price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...